GlassScriptPhysician profile
Christina L Sikes
NPI 1396062238
$3,188.61
in general payments reported to CMS, 2019-2025
30 companies · $672 in 2025
The $672 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $283 · 2021: $220 · 2022: $567 · 2023: $299 · 2024: $1,039 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855 · Charitable Contribution: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.54 |
| Charitable Contribution | $154.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $689.01 | 2022-2025 | Affinity, Puraply, Puraply Wound Matrix |
| Smith+Nephew, INC. | $683.40 | 2022-2025 | Grafix Pl, Oasis, Stravix |
| Polymedics Innovations INC. | $297.38 | 2023-2025 | |
| Next Science LLC | $251.16 | 2024 | Surgx, Blastx, Xperience |
| Paratek Pharmaceuticals, INC. | $185.92 | 2020-2023 | Nuzyra |
| Bioventus LLC | $148.61 | 2022 | |
| Convatec INC. | $98.80 | 2022-2024 | |
| Amgen INC. | $91.88 | 2019-2021 | |
| Abbvie INC. | $79.32 | 2021-2025 | |
| Solventum Corporation | $73.02 | 2024-2025 | Activ.A.C., 3m Cavilon, Kerramax Care |
| Dexcom, INC. | $59.70 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.39 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $50.62 | 2020-2021 | |
| Medline Industries LP | $48.61 | 2025 | |
| Cashflow Solutions, LLC | $37.66 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $35.42 | 2019-2021 | |
| Hydrofera LLC | $30.95 | 2022-2024 | Hydrofera Blue |
| Esperion Therapeutics, INC. | $30.83 | 2020-2021 | |
| Ets Wound Care LLC | $28.33 | 2025 | Mirragen Advanced Wound Matrix |
| Melinta Therapeutics, LLC | $27.52 | 2022-2023 | Orbactiv, Kimyrsa |
| Tactile Systems Technology INC | $22.74 | 2025 | Nimbl, Flexitouch Plus |
| Allergan, INC. | $22.16 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $21.65 | 2021 | |
| Abbott Laboratories | $21.15 | 2021 | |
| Kci USA, INC. | $19.11 | 2022 | |
| Progenacare Global, LLC | $18.22 | 2024 | |
| Hollister Incorporated | $16.96 | 2025 | New Image |
| Astrazeneca Pharmaceuticals LP | $13.90 | 2019 | |
| Molnlycke Health Care US, LLC | $12.75 | 2024 | Melgisorb Plus, Mepitel One, Exufiber Ag+ |
| Lilly USA, LLC | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Sikes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.